These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12212666)

  • 1. Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease.
    Frodl T; Hampel H; Juckel G; Bürger K; Padberg F; Engel RR; Möller HJ; Hegerl U
    Psychophysiology; 2002 Mar; 39(2):175-81. PubMed ID: 12212666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment.
    Bennys K; Portet F; Touchon J; Rondouin G
    J Clin Neurophysiol; 2007 Oct; 24(5):405-12. PubMed ID: 17912065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of event-related potentials in cognitive decline in Alzheimer's disease.
    Lai CL; Lin RT; Liou LM; Liu CK
    Clin Neurophysiol; 2010 Feb; 121(2):194-9. PubMed ID: 20005164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic usefulness of cognitive auditory event-related p300 subcomponents in patients with Alzheimers disease?
    Juckel G; Clotz F; Frodl T; Kawohl W; Hampel H; Pogarell O; Hegerl U
    J Clin Neurophysiol; 2008 Jun; 25(3):147-52. PubMed ID: 18469731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Working memory load-related electroencephalographic parameters can differentiate progressive from stable mild cognitive impairment.
    Missonnier P; Deiber MP; Gold G; Herrmann FR; Millet P; Michon A; Fazio-Costa L; Ibañez V; Giannakopoulos P
    Neuroscience; 2007 Dec; 150(2):346-56. PubMed ID: 17996378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The P300 component in patients with Alzheimer's disease and their biological children.
    Ally BA; Jones GE; Cole JA; Budson AE
    Biol Psychol; 2006 May; 72(2):180-7. PubMed ID: 16337071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Auditory P300 in assessing cognitive dysfunctions of Alzheimer's disease and schizophrenia].
    Zhang M; Chen X; Lou F
    Zhonghua Yi Xue Za Zhi; 1998 Jun; 78(6):454-6. PubMed ID: 10923511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of event-related potentials in the assessment of mild cognitive impairment.
    Papaliagkas V; Kimiskidis V; Tsolaki M; Anogianakis G
    BMC Neurosci; 2008 Nov; 9():107. PubMed ID: 18986528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurophysiological study and use of P300 evoked potentials for investigation in the diagnosis and of follow-up of patients with Alzheimer s disease].
    Fernández- Lastra A; Morales-Rodríguez M; Penzol-Díaz J
    Rev Neurol; 2001 Mar 16-31; 32(6):525-8. PubMed ID: 11353989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response speed, contingent negative variation and P300 in Alzheimer's disease and MCI.
    van Deursen JA; Vuurman EF; Smits LL; Verhey FR; Riedel WJ
    Brain Cogn; 2009 Apr; 69(3):592-9. PubMed ID: 19185407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [P300 in mild cognitive impairment and in dementia].
    Egerházi A; Glaub T; Balla P; Berecz R; Degrell I
    Psychiatr Hung; 2008; 23(5):349-57. PubMed ID: 19129551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P300 event-related potentials and cognitive function in social phobia.
    Sachs G; Anderer P; Margreiter N; Semlitsch H; Saletu B; Katschnig H
    Psychiatry Res; 2004 Sep; 131(3):249-61. PubMed ID: 15465294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modality-specific changes in P300 parameters in patients with dementia of the Alzheimer type.
    Pokryszko-Dragan A; Słotwiński K; Podemski R
    Med Sci Monit; 2003 Apr; 9(4):CR130-4. PubMed ID: 12709671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological correlates of the P300 in patients with Alzheimer's disease.
    Lee MS; Lee SH; Moon EO; Moon YJ; Kim S; Kim SH; Jung IK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():62-9. PubMed ID: 22940475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can age-dependent cognitive functions be measured? P300 potentials--concept of brain aging--early diagnosis of dementia processes].
    Kügler C
    Fortschr Med; 1996 Oct; 114(28):357-60. PubMed ID: 9011530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P300 energy loss in aging and Alzheimer's disease.
    Ashford JW; Coburn KL; Rose TL; Bayley PJ
    J Alzheimers Dis; 2011; 26 Suppl 3():229-38. PubMed ID: 21971463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly.
    Tanriverdi F; Yapislar H; Karaca Z; Unluhizarci K; Suer C; Kelestimur F
    Growth Horm IGF Res; 2009 Feb; 19(1):24-30. PubMed ID: 18567522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
    Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
    Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
    Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
    Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.